This blog is written by Chris Threapleton, an Early Career Researcher, who published ‘Development of a structured clinical pharmacology review for specialist support for management of complex…
For many doctors, in the UK and further afield, the emergence of a global pandemic has seen them seconded from their usual area and/or training to the COVID-19 effort. Clinical pharmacologists are no…
The British Pharmacological Society is delighted to announce that Professor David Webb, President of the Society from 2016 to 2018, is to be awarded Commander of the British Empire (CBE) in the…
Ahead of World Mental Health Day on 10 October 2020, our CEO Rachel Lambert-Forsyth shares how the Society, as an employer, has taken on the unique mental health challenges posed by COVID-19.
The BPS Community has played an important role for the Society during the pandemic. It has allowed us to keep conversations flowing and communication channels open. Being a virtual platform, it has…
Today, the Association of the British Pharmaceutical Industry (ABPI) publishes its Clinical Trials Report for 2020, highlighting that the UK has been leading the rest of Europe in early-stage…
--This blog also appears on the partner ELRIG UK’s website--It’s difficult to summarize Graham Russell’s contribution to medicine with brevity. The development of bisphosphonates for the treatment of…
The theme of this year’s Black History Month is “Dig Deeper, Look Closer, Think Bigger”. At the Society, we will be doing this by: celebrating Black contributions to pharmacology and drug…
As we enter the autumn months, the UK is seeing the start of the anticipated “second wave” of COVID-19 infections, with local restrictions coming into force to try to slow the spread of the virus…
The Prescribing Safety Assessment (PSA), developed and delivered by the British Pharmacological Society and MSC Assessment, is celebrating its 10th year. The PSA allows all students to demonstrate…
